Comparison

Cabazitaxel European Partner

Item no. TMO-T2543-20mg
Manufacturer TargetMol
CASRN 183133-96-2
Amount 20 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 20 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias XRP6258,RPR-116258A,TXD 258,taxoid XRP6258
Shipping Condition Cool pack
Available
Manufacturer - Targets
Autophagy|||Microtubule Associated
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
835.93
Description
Cabazitaxel (taxoid XRP6258) is a taxane and antineoplastic agent which is currently used in the therapy of castration-resistant metastatic prostate cancer after failure of docetaxel.
Pathways
Autophagy|||Cytoskeletal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 20 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close